首页> 外国专利> Use of Immunoglobulin for Intravenous Use in the Preparation of a Pharmaceutical Composition for the Treatment of Cancer Diseases

Use of Immunoglobulin for Intravenous Use in the Preparation of a Pharmaceutical Composition for the Treatment of Cancer Diseases

机译:免疫球蛋白在静脉内用于制备治疗癌症疾病的药物组合物中的用途

摘要

This invention provides therapeutic methods for inhibiting tumor metastasis and for treating primary tumors. The methods of this invention do not cause serious side effects and will be effective for a broad spectrum of cancerous diseases. In particular, the invention discloses a novel method comprising administering to a mammal a preparation of intravenous immunoglobulin (IVIG). The IVIG preparation to be administered according to this invention may contain intact immunoglobulin molecules or fragments of immunoglobulins. The preparation is administered parenterally, preferably via intravenous, intracavitary or subcutaneous routes, either as a sole agent or in combination with other agents or methods which are commonly used for cancer treatment.
机译:本发明提供了抑制肿瘤转移和治疗原发性肿瘤的治疗方法。本发明的方法不会引起严重的副作用,并且对于多种癌症疾病将是有效的。特别地,本发明公开了一种新颖的方法,其包括向哺乳动物施用静脉内免疫球蛋白(IVIG)的制剂。根据本发明要施用的IVIG制剂可以包含完整的免疫球蛋白分子或免疫球蛋白片段。肠胃外给药,优选通过静脉内,腔内或皮下途径,作为单独的药物或与其他通常用于癌症治疗的药物或方法联合使用。

著录项

  • 公开/公告号FI114011B

    专利类型

  • 公开/公告日2004-07-30

    原文格式PDF

  • 申请/专利权人 ARP BIOMED LTD;

    申请/专利号FI19960003598

  • 发明设计人 SHOENFELDYEHUDA;FISHMANPNINA;

    申请日1996-09-12

  • 分类号A61K39/395;

  • 国家 FI

  • 入库时间 2022-08-21 23:11:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号